MICHAEL R. ACHONG, M.B.; PAUL M. KEANE, M.B.
Three previous case reports have described hemodynamic abnormalities precipitated or triggered by imipramine therapy and leading to recognition of pheochromocytoma (1-3). It has been uncertain whether therapy with other tricyclic antidepressants may unmask pheochromocytoma. We describe the unmasking of pheochromocytoma by desipramine therapy in a patient who showed no adverse effect while receiving amitriptyline intermittently over 9 years.
A 56-year-old woman presented with a history of severe headache and nausea with vomiting for 2 days. Her symptoms had begun after two doses of desipramine (Norpramin, Merrell-National Laboratories, Cincinnati, Ohio), 25 mg, and ketoprofen (Orudis, Poulenc, Ltd., Montreal, Quebec, Canada). She
ACHONG MR, KEANE PM. Pheochromocytoma Unmasked by Desipramine Therapy. Ann Intern Med. ;94:358–359. doi: 10.7326/0003-4819-94-3-358
Download citation file:
Published: Ann Intern Med. 1981;94(3):358-359.
Adrenal Disorders, Endocrine and Metabolism, Endocrine Cancer, Hematology/Oncology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use